Cimicifuga – Effects, Uses and Safety
Cimicifuga is a medicinal plant used to relieve menopausal symptoms. Its root contains bioactive compounds that may exert hormone-like effects on the body.
Things worth knowing about "Cimicifuga"
Cimicifuga is a medicinal plant used to relieve menopausal symptoms. Its root contains bioactive compounds that may exert hormone-like effects on the body.
What is Cimicifuga?
Cimicifuga racemosa, commonly known as black cohosh (also classified scientifically as Actaea racemosa), is a perennial medicinal plant native to North America. It belongs to the buttercup family (Ranunculaceae). Indigenous peoples of North America traditionally used it to treat women's health issues and rheumatic complaints. Today, it is primarily used as a herbal remedy for menopausal symptoms and is approved as a medicinal product in many countries.
Active Compounds
The medically relevant active ingredients are found mainly in the root stock (rhizome) of the plant. The key compounds include:
- Triterpene glycosides (e.g., actein, cimicifugoside): considered the primary active substances
- Phenolic acids (e.g., isoferulic acid): with antioxidant properties
- Flavonoids: supporting bioactive compounds
- Alkaloids (e.g., N-methylserotonin): potentially involved in central nervous system effects
Mechanism of Action
The exact mechanism of action of cimicifuga has not yet been fully clarified. For a long time, it was assumed that the plant had phytoestrogenic properties -- that is, it acted similarly to estrogen. However, more recent studies suggest that its effects are primarily mediated through serotonergic and dopaminergic pathways in the brain, influencing hot flushes and mood changes. A direct activation of estrogen receptors is now considered less likely, which makes cimicifuga potentially relevant for women with hormone-sensitive conditions -- although medical advice is essential in these cases.
Medical Uses
Cimicifuga extracts are primarily used for the treatment of the following conditions:
- Hot flushes and night sweats during menopause
- Sleep disturbances and nervousness
- Mood swings and depressive episodes during menopause
- Premenstrual syndrome (PMS): investigated in some studies
In many countries, cimicifuga preparations are approved as herbal medicinal products (phytomedicines). The European Medicines Agency (EMA) has recognised a well-established use for cimicifuga dry extracts in the treatment of menopausal complaints.
Dosage and Usage Notes
The standard daily dose according to approvals and clinical studies is:
- 20–40 mg dry extract from the rhizome, usually as film-coated tablets or capsules
- The duration of use should generally not exceed 6 months without consulting a physician
It is important to use standardised extracts and to follow the package instructions and medical guidance.
Safety and Side Effects
Cimicifuga is generally considered well tolerated when used as directed. Possible side effects include:
- Gastrointestinal discomfort and nausea
- Skin reactions (rare)
- Headaches
In rare cases, liver damage has been reported in connection with cimicifuga preparations. A causal relationship has not been conclusively established; however, if symptoms such as jaundice, dark urine, or severe fatigue occur, a doctor should be consulted immediately.
Contraindications
- Known hypersensitivity to cimicifuga or related plants
- Existing liver disease
- Pregnancy and breastfeeding (due to insufficient safety data)
- Hormone-dependent conditions (e.g., estrogen-dependent breast cancer): only after medical consultation
Interactions
Cimicifuga may potentially interact with the following substances:
- Hepatotoxic medications: increased risk of liver damage
- Hormonal preparations (e.g., tamoxifen): possible impact on efficacy
- Antihypertensive agents: potential additive effects
Scientific Evidence
Numerous clinical studies have investigated the efficacy of cimicifuga for menopausal symptoms. Several randomised controlled trials and meta-analyses demonstrate a significant reduction in hot flushes and an improvement in quality of life compared to placebo. The level of evidence is assessed by the EMA and various medical associations as sufficient to support clinical use, although further large-scale studies would be beneficial.
References
- European Medicines Agency (EMA): Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma. EMA/HMPC/600717/2013.
- Leach MJ, Moore V: Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews, 2012.
- Borrelli F, Ernst E: Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. American Journal of Obstetrics and Gynecology, 2008.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryTestosterone deficiency
Aortic valve stenosis
Coxarthrosis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Cimicifuga